Search details
1.
SERT and NET polymorphisms, temperament and antidepressant response.
Nord J Psychiatry
; 69(7): 531-8, 2015.
Article
in English
| MEDLINE | ID: mdl-25739526
2.
High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth.
Prostate
; 72(15): 1678-87, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22473923
3.
Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer.
J Pathol
; 223(4): 543-52, 2011 Mar.
Article
in English
| MEDLINE | ID: mdl-21294127
4.
Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?
Eur Arch Psychiatry Clin Neurosci
; 261(2): 95-102, 2011 Mar.
Article
in English
| MEDLINE | ID: mdl-20640435
5.
GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype.
Hum Mutat
; 30(5): 724-33, 2009 May.
Article
in English
| MEDLINE | ID: mdl-19338053
6.
Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.
Hum Mutat
; 29(3): 409-17, 2008 Mar.
Article
in English
| MEDLINE | ID: mdl-18059020
7.
Androgen receptor amplification is associated with increased cell proliferation in prostate cancer.
Hum Pathol
; 38(3): 474-8, 2007 Mar.
Article
in English
| MEDLINE | ID: mdl-17217995
8.
Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression.
Neurosci Lett
; 590: 116-20, 2015 Mar 17.
Article
in English
| MEDLINE | ID: mdl-25650523
9.
BRCA2 mutations in 154 finnish male breast cancer patients.
Neoplasia
; 6(5): 541-5, 2004.
Article
in English
| MEDLINE | ID: mdl-15548363
10.
MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.
Medicine (Baltimore)
; 82(3): 203-15, 2003 May.
Article
in English
| MEDLINE | ID: mdl-12792306
11.
Incidence of cancer in finnish families with clinically aggressive and nonaggressive prostate cancer.
Cancer Epidemiol Biomarkers Prev
; 18(11): 3049-56, 2009 Nov.
Article
in English
| MEDLINE | ID: mdl-19843684
12.
Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance.
Hum Genet
; 121(2): 257-67, 2007 Apr.
Article
in English
| MEDLINE | ID: mdl-17203302
13.
Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients.
Int J Cancer
; 118(2): 518-20, 2006 Jan 15.
Article
in English
| MEDLINE | ID: mdl-16003728
14.
Expression patterns of potential therapeutic targets in prostate cancer.
Int J Cancer
; 113(4): 619-28, 2005 Feb 10.
Article
in English
| MEDLINE | ID: mdl-15472903
15.
Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus.
Hum Genet
; 116(1-2): 43-50, 2005 Jan.
Article
in English
| MEDLINE | ID: mdl-15549392
16.
Germline mutation analysis of the androgen receptor gene in Finnish patients with prostate cancer.
J Urol
; 171(1): 431-3, 2004 Jan.
Article
in English
| MEDLINE | ID: mdl-14665948
17.
Kruppel-like factor 6 germ-line mutations are infrequent in Finnish hereditary prostate cancer.
J Urol
; 172(2): 506-7, 2004 Aug.
Article
in English
| MEDLINE | ID: mdl-15247715
18.
Androgen receptor gene alterations in Finnish male breast cancer.
Breast Cancer Res Treat
; 77(2): 167-70, 2003 Jan.
Article
in English
| MEDLINE | ID: mdl-12602915
19.
Defining the region(s) of deletion at 6q16-q22 in human prostate cancer.
Genes Chromosomes Cancer
; 34(3): 306-12, 2002 Jul.
Article
in English
| MEDLINE | ID: mdl-12007191
20.
Androgen receptor mutations in high-grade prostate cancer before hormonal therapy.
Lab Invest
; 83(12): 1709-13, 2003 Dec.
Article
in English
| MEDLINE | ID: mdl-14691288